Sudden visual loss in the untreated eye of a patient with neovascular glaucoma following an intravitreal bevacizumab injection: A case report

By        

Oncology Letters, Vol. 6, Iss. 2, 2013-01 ,pp. : 445-447

Spandidos Publications

Access to resources Recommend Favorite

Overall and progression-free survival and visual and endocrine outcomes for patients with parasellar lesions treated with intensity-modulated stereotactic radiosurgery

By Jensen Randy   Jensen Peter   Shrieve Annabelle   Hazard Lisa   Shrieve Dennis  

Journal of Neuro-Oncology, Vol. 98, Iss. 2, 2010-06 ,pp. : 221-231

Springer Publishing Company

Access to resources Recommend Favorite

Management of venous thromboembolism in colorectal cancer patients treated with bevacizumab

By Suenaga Mitsukuni   Mizunuma Nobuyuki   Kobayashi Kokoro   Shinozaki Eiji   Matsusaka Satoshi   Chin Keisho   Kuboki Yasutoshi   Ichimura Takashi   Ozaka Masato   Ogura Mariko   Fujiwara Yoshimasa   Matsueda Kiyoshi   Konishi Fumio   Hatake Kiyohiko  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 807-814

Humana Press, Inc

Access to resources Recommend Favorite

Correlation of MRI sequences to assess progressive glioblastoma multiforme treated with bevacizumab

By Thompson Eric   Dosa Edit   Kraemer Dale   Neuwelt Edward  

Journal of Neuro-Oncology, Vol. 103, Iss. 2, 2011-06 ,pp. : 353-360

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer

By Larsen Finn Ole   Boisen Mogens Karsbøl   Fromm Annelene L.   Jensen Benny Vittrup  

Acta Oncologica, Vol. 51, Iss. 2, 2012-02 ,pp. : 231-233

Informa Healthcare

Access to resources Recommend Favorite